‘Mistaken’ Release of Glyphosate Report Raises Questions Over EPA’s Ties to Monsanto
Monsanto has vehemently denied cancer claims of its blockbuster product and has demanded a retraction of the IARC report.
WHO classifies atrazine as ‘probably carcinogenic to humans’ raising concerns about toxic exposure
This new evaluation confirms both the first—glyphosate—and second most used herbicides in the nation’s farm belt carry potential health and environmental concerns.
As wealthy nations debate giving booster vaccine shots, calls grow for global vaccine equity
“This is an emergency that affects all of us because variants are coming from areas where there are large numbers of unvaccinated people.”
Flint residents face crackdowns for not paying for poisoned water
Meanwhile, three years after the Flint water crisis began, pipes still have not been fixed and water is still considered unsafe to drink.
Bernie Sanders to host Medicare for All national town hall meeting with leading digital...
"We are going outside the traditional media to change that, to talk about the real issues affecting the American people."
How much sleep do I need? Why you can forget the eight-hour rule
Eight hours isn’t necessarily the magic number for sleep. Your age, body clock and individual needs all matter.
What is our collective solution to health injustice?
The fight over health care in the U.S. is about competing narratives: profit-making versus collective well-being. We need to articulate a publicly funded solution now—before corporate spin silences us.
No, Paul, it wasn’t because of “growing pains”
America and the rest of the world must hold our collective breath, hoping that the next elections – the midterms of 2018 and then the presidential election of 2020 – set things right.
Reducing climate change will prevent future deadly epidemics says new study
"Recent outbreaks of animal-borne emerging infectious diseases have likely been precipitated by a complex interplay of changing ecological, epidemiological and socio-economic factors."
We gave Pharma a blank check, now we’re paying the bill
We can and should ask our policymakers to rewrite the rules of our economy and rebuild a pharmaceutical industry that is designed to serve the needs of patients, not profits.